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Sir,
We read with interest the paper by Pabst and coworkers, “C1-
esterase inhibitor deficiency in pediatric heart transplant re-
cipients: incidence and findings on ultrasound” [1], and
would like to comment. The retrospective study described a
cohort of 207 children and adolescents who had undergone
heart transplantation and were treated with immune inhibitors
and angiotensin converting enzyme inhibitors. In three pa-
tients, abdominal angioedema was suspected based on a sud-
den onset of abdominal pain, a thickened bowel wall and
presence of ascites. The symptoms and signs resolved spon-
taneously after a mean of 3 days supporting the diagnosis of
angioedema. The authors importantly emphasized awareness
of this condition with associated radiologic findings to avoid
unnecessary surgical exploration.
According to the title of the paper, C1-esterase inhibitor
deficiency was found. We searched with interest for these data
in the article, however despite detailed reading and personal
communication with the corresponding author, we realise that
C1-esterase inhibitor measurements were not performed. This
means that the title and some of the conclusions should be
changed.
C1-esterase inhibitor deficiency is a rare condition seen in
patients with hereditary angioedema (prevalence around
1:70,000) or acquired angioedema with C1-esterase inhibitor
deficiency reported in fewer than 200 patients worldwide [2, 3].
We are not aware of any patients with angiotensin converting
enzyme-inhibitor or immune inhibitor induced acquired angio-
edema with C1-esterase inhibitor deficiency documented in the
literature and neither found that such a condition was reported
in this study.
In the present study, two of the three reported cases were
treated with everolimus and an angiotensin converting
enzyme inhibitor (lisinopril) while the third case was treat-
ed with tacrolimus but did not receive any angiotensin
converting enzyme inhibitor. Both immune inhibitors
alone or in combination with angiotensin converting en-
zyme inhibitors have earlier been reported to induce an-
gioedema. Cases of drug-induced acquired angioedema do
not have C1-esterase inhibitor deficiency, which is errone-
ously mentioned in the discussion section of the paper with
a reference to Zvidi et al. [4].
In conclusion, the paper describes and illustrates very
nicely three patients with probable drug-induced abdominal
angioedema, which seems to be a risk in heart transplant
recipients treated with everolimus, tacrolimus and/or angio-
tensin converting enzyme inhibitors. The mechanism of the
latter condition is not C1-esterase inhibitor deficiency but
possibly a decreased degradation of bradykinin [5].
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